These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33111624)

  • 1. Deciphering underlying mechanism of Sars-CoV-2 infection in humans and revealing the therapeutic potential of bioactive constituents from
    Jakhmola Mani R; Sehgal N; Dogra N; Saxena S; Pande Katare D
    J Biomol Struct Dyn; 2022 Apr; 40(6):2417-2429. PubMed ID: 33111624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual screening of phytoconstituents from miracle herb
    Siddiqui S; Upadhyay S; Ahmad R; Gupta A; Srivastava A; Trivedi A; Husain I; Ahmad B; Ahamed M; Khan MA
    J Biomol Struct Dyn; 2022 Jun; 40(9):3928-3948. PubMed ID: 33289456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular docking, simulation and MM-PBSA studies of
    Ahmad S; Abbasi HW; Shahid S; Gul S; Abbasi SW
    J Biomol Struct Dyn; 2021 Aug; 39(12):4225-4233. PubMed ID: 32462996
    [No Abstract]   [Full Text] [Related]  

  • 4. Revisiting pharmacological potentials of Nigella sativa seed: A promising option for COVID-19 prevention and cure.
    Islam MN; Hossain KS; Sarker PP; Ferdous J; Hannan MA; Rahman MM; Chu DT; Uddin MJ
    Phytother Res; 2021 Mar; 35(3):1329-1344. PubMed ID: 33047412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible therapeutic effects of
    Khazdair MR; Ghafari S; Sadeghi M
    Pharm Biol; 2021 Dec; 59(1):696-703. PubMed ID: 34110959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro potential antiviral SARS-CoV-19- activity of natural product thymohydroquinone and dithymoquinone from Nigella sativa.
    Esharkawy ER; Almalki F; Hadda TB
    Bioorg Chem; 2022 Mar; 120():105587. PubMed ID: 35026560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Inhibitors from Nigella Sativa.
    Baig A; Srinivasan H
    Appl Biochem Biotechnol; 2022 Mar; 194(3):1051-1090. PubMed ID: 35102539
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Koshak DAE; Koshak PEA
    Curr Ther Res Clin Exp; 2020; 93():100602. PubMed ID: 32863400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Silico Investigation of the SARS CoV2 Protease with Thymoquinone, the Major Constituent of Nigella Sativa.
    Kadil Y; Mouhcine M; Filali H
    Curr Drug Discov Technol; 2021; 18(4):570-573. PubMed ID: 32652915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies.
    Ali AM; Kunugi H
    Molecules; 2021 Feb; 26(5):. PubMed ID: 33669054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Studies on Zinc Oxide Based Nanostructured Oil Carriers with Seed Extracts of
    Hendi AA; Virk P; Awad MA; Elobeid M; Ortashi KMO; Alanazi MM; Alkallas FH; Almoneef MM; Abdou MA
    Molecules; 2022 Jul; 27(13):. PubMed ID: 35807545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Approach for the Evaluation of the Potential Antiviral Activity of Extra Virgin Olive Oil (EVOO) Bioactive Constituents Oleuropein and Oleocanthal on Spike Therapeutic Drug Target of SARS-CoV-2.
    Geromichalou EG; Geromichalos GD
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural interactions of phytoconstituent(s) from cinnamon, bay leaf, oregano, and parsley with SARS-CoV-2 nucleocapsid protein: A comparative assessment for development of potential antiviral nutraceuticals.
    Husain I; Ahmad R; Siddiqui S; Chandra A; Misra A; Srivastava A; Ahamad T; Khan MF; Siddiqi Z; Trivedi A; Upadhyay S; Gupta A; Srivastava AN; Ahmad B; Mehrotra S; Kant S; Mahdi AA; Mahdi F
    J Food Biochem; 2022 Oct; 46(10):e14262. PubMed ID: 35796388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytoconstituents from Moringa oleifera fruits target ACE2 and open spike glycoprotein to combat SARS-CoV-2: An integrative phytochemical and computational approach.
    Siddiqui S; Ahmad R; Alaidarous M; Zia Q; Ahmad Mir S; Alshehri B; Srivastava A; Trivedi A
    J Food Biochem; 2022 May; 46(5):e14062. PubMed ID: 35043973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of thymoquinone from Nigella sativa against SARS-CoV-2 main protease. An in-silico study.
    Khan MT; Ali A; Wei X; Nadeem T; Muhammad S; Al-Sehemi AG; Wei D
    Braz J Biol; 2022; 84():e250667. PubMed ID: 35475989
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Imran M; Khan SA; Abida ; Alshammari MK; Alkhaldi SM; Alshammari FN; Kamal M; Alam O; Asdaq SMB; Alzahrani AK; Jomah S
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
    Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Active Compounds of Nigella sativa in COVID-19: A Narrative Review.
    H U; S M; A A; Pk M; R K; R D; D S; Aa M; Panda PK
    Recent Adv Antiinfect Drug Discov; 2023 Feb; ():. PubMed ID: 36815641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential influence of Nagella sativa (Black cumin) in reinforcing immune system: A hope to decelerate the COVID-19 pandemic.
    Kulyar MF; Li R; Mehmood K; Waqas M; Li K; Li J
    Phytomedicine; 2021 May; 85():153277. PubMed ID: 32773257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.
    Offringa A; Montijn R; Singh S; Paul M; Pinto YM; Pinto-Sietsma SJ
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):317-325. PubMed ID: 32464637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.